v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 22,552 $ 24,365
Trade accounts receivable, net of allowance for credit losses of $28 and $35, respectively 1,190 1,670
Inventories, current 3,794 4,020
Other current assets 907 826
Total current assets 28,443 30,881
Property, plant and equipment, net 3,859 4,085
Inventories, noncurrent 331 379
Other noncurrent assets 202 129
Total assets 32,835 35,474
Current liabilities    
Accounts payable 429 291
Income taxes payable 1  
Accrued expense 820 981
Contract liabilities 893 1,255
Other current liabilities 46 121
Total current liabilities 2,189 2,648
Contract liabilities, noncurrent 854 751
Warrants 10 10
Deferred tax liabilities, net 63 33
Total liabilities 3,116 3,442
Commitments and contingencies (Note 13)
Shareholders' equity    
Common stock, $0.0001 par value; 300,000,000 shares authorized as of March 31, 2026 and December 31, 2025, and 2,012,297 and 2,007,613 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively and no shares issued or outstanding as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital 98,529 98,371
Accumulated deficit (68,810) (66,339)
Total shareholders' equity 29,719 32,032
Total liabilities and shareholders' equity $ 32,835 $ 35,474